Theglobeandmail

Published September 24, 2026 · Updated September 25, 2026

Psyence Biomedical Launches Texas Ibogaine Unit and Commits Up to US$5 Million in PsyLabs

Read the full story at Theglobeandmail

Ibogaine Research Corporation in Texas to coordinate regulatory, clinical and development activities. The move aims to position the company within.